Distinct role of the intracellular C-terminus for subcellular expression, shedding and function of the murine transmembrane chemokine CX3CL1

被引:13
|
作者
Andrzejewski, Michael G. [1 ]
Koelsch, Anne [2 ]
Kogel, Tanja [3 ]
Dreymueller, Daniela [3 ]
Schwarz, Nicole [3 ]
Ludwig, Andreas [1 ,3 ]
机构
[1] Rhein Westfal TH Aachen, Inst Pharmacol & Toxicol, D-52074 Aachen, Germany
[2] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, D-52074 Aachen, Germany
[3] Rhein Westfal TH Aachen, Interdisciplinary Ctr Clin Res Biomat, D-52074 Aachen, Germany
关键词
Chemokine; Metalloproteinase; Shedding; Adhesion; Transmigration; ALPHA-CONVERTING ENZYME; EPIDERMAL-GROWTH-FACTOR; CELL-ADHESION; TNF-ALPHA; IFN-GAMMA; FRACTALKINE; CLEAVAGE; DISINTEGRIN; BINDING; DOMAIN;
D O I
10.1016/j.bbrc.2010.03.139
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transmembrane chemokine CX3CL1 is expressed on the endothelial surface and promotes leukocyte adhesion and transmigration by receptor interaction via its extracellular chemokine domain. Since little is known about its intracellular C-terminus, we examined the consequences of C-terminal truncation on cellular distribution, proteolytic shedding and function of murine CX3CL1. Full length murine CX3CL1 was expressed and shed by the metalloproteinase ADAM10 as described for human CX3CL1. Truncation of murine CX3CL1 led to reduced maturation and impaired trafficking to the surface. Truncation of CX3CL1 also abrogated localization to early endosomal vesicles, but increased shedding from the surface by ADAM10. Once truncated CX3CL1 was expressed on the surface, it mediated cell contact and induced leukocyte transmigration similar as full length CX3CL1. These data suggest that the C-terminus of CX3CL1 carries important determinants for cellular trafficking but not for function of the chemokine during leukocyte recruitment. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 47 条
  • [41] The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK
    Green, Simone R.
    Han, Ki Hoon
    Chen, Yiming
    Almazan, Felicidad
    Charo, Israel F.
    Miller, Yury I.
    Quehenberger, Oswald
    JOURNAL OF IMMUNOLOGY, 2006, 176 (12): : 7412 - 7420
  • [42] Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis-possible role in vascular inflammation
    Bjerkeli, Vigdis
    Damas, Jan Kristian
    Fevang, Borre
    Holter, Jan Cato
    Aukrust, Pal
    Froland, Stig S.
    RHEUMATOLOGY, 2007, 46 (09) : 1422 - 1427
  • [43] Berberine Suppresses Leukocyte Adherence by Downregulating CX3CL1 Expression and Shedding and ADAM10 in Lipopolysaccharide-Stimulated Vascular Endothelial Cells
    Wu, Yi-Hong
    Wei, Chen-Ying
    Hong, Wei-Chin
    Pang, Jong-Hwei Su
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [44] Role of ADAM-17, p38 MAPK, Cathepsins, and the Proteasome Pathway in the Synthesis and Shedding of Fractalkine/CX3CL1 in Rheumatoid Arthritis
    Jones, Brian A.
    Riegsecker, Sharayah
    Rahman, Ayesha
    Beamer, Maria
    Aboualaiwi, Wissam
    Khuder, Sadik A.
    Ahmed, Salahuddin
    ARTHRITIS AND RHEUMATISM, 2013, 65 (11): : 2814 - 2825
  • [45] Toll-like receptor-4 (TLR4) regulates expression of Cx3cl1 (fractalkine) and its receptor Cx3cr1 in a murine model of inflammatory bowel disease (IBD)
    Goo, Tyralee
    Fukata, Masayuki
    Chen, Anli
    Conduah, Daisy
    Breglio, Keith
    Hsu, David
    Abreu, Maria T.
    GASTROENTEROLOGY, 2007, 132 (04) : A707 - A707
  • [46] MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy
    Yun, Jie
    Ren, Jinyu
    Liu, Yufei
    Dai, Lijuan
    Song, Liqun
    Ma, Xiaopeng
    Luo, Shan
    Song, Yexu
    BIOENGINEERED, 2022, 13 (01) : 634 - 644
  • [47] Thrombi-induced expression of endothelial CX3CL1 amplifies monocytic/endothelial cell cross-talk and subsequent chemokine induction through activation of NF-κB signaling
    Laumonnier, Y.
    Popovic, M.
    Burysek, L.
    Syrovets, T.
    Simmet, Th.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 51 - 51